PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,515,652 | -13.0% | 2,495,770 | 0.0% | 0.80% | +17.3% |
| Q1 2023 | $6,339,256 | +2853.7% | 2,495,770 | +2074.6% | 0.69% | +3935.3% |
| Q4 2022 | $214,620 | -27.2% | 114,770 | 0.0% | 0.02% | -15.0% |
| Q3 2022 | $295,000 | +32.9% | 114,770 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $222,000 | -34.9% | 114,770 | 0.0% | 0.02% | -54.5% |
| Q1 2022 | $341,000 | -33.9% | 114,770 | 0.0% | 0.04% | -39.7% |
| Q4 2021 | $516,000 | -59.9% | 114,770 | -56.7% | 0.07% | -67.0% |
| Q3 2021 | $1,287,000 | -28.7% | 264,770 | 0.0% | 0.22% | -43.9% |
| Q2 2021 | $1,806,000 | +89.9% | 264,770 | +96.5% | 0.39% | +58.9% |
| Q1 2021 | $951,000 | +8.4% | 134,770 | -3.7% | 0.25% | -13.9% |
| Q4 2020 | $877,000 | +15.7% | 140,020 | 0.0% | 0.29% | +68.4% |
| Q3 2020 | $758,000 | +3.7% | 140,020 | 0.0% | 0.17% | +3.6% |
| Q2 2020 | $731,000 | +44.2% | 140,020 | -13.0% | 0.16% | +71.9% |
| Q1 2020 | $507,000 | -87.0% | 160,870 | -83.4% | 0.10% | -67.6% |
| Q4 2019 | $3,895,000 | -6.7% | 966,493 | 0.0% | 0.30% | +13.8% |
| Q3 2019 | $4,176,000 | – | 966,493 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |